ABMD - Could Abiomed Be a Millionaire-Maker Stock?
Abiomed (NASDAQ: ABMD) shares have tripled in value over the past five years. That's as the company brought its heart pumps to more and more patients. And recently, Abiomed even has become a player in the coronavirus market. The U.S. Food and Drug Administration has authorized its pumps for the treatment of some hospitalized coronavirus patients.
In more good news, the company reported record revenue in the most recent quarter. That happened even as hospitals delayed some medical procedures due to the coronavirus pandemic. As the crisis eases, it's logical to expect procedure volume to pick up. This should mean more revenue and profit on the horizon. But does it also mean buying Abiomed shares might make you a millionaire? Let's find out.
Image source: Getty Images.
For further details see:
Could Abiomed Be a Millionaire-Maker Stock?